A case of synthetic cannabinoid poisoning in Croatia

Sutlović, Davorka; Prkačin, Ingrid; Vaiano, Fabio; Bertol, Elisabetta; Bratinčević, Maja Veršić; Definis-Gojanović, Marija

doi:10.2478/aiht-2018-69-3100

References

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol. EU Drug Markets Report: Strategic Overview. Luxembourg: EMCDDA, Europol; 2016. doi: 10.2810/21624810.2810/216248
Open DOI Search in Google Scholar Back to article
2. Vlada Republike Hrvatske. Protokol o nacionalnom informacijskom sustavu za droge u Republici Hrvatskoj [Croatian Protocol on the National Information Drugs System, in Croatian]. Zagreb: Ured za suzbijanje zlouporabe opojnih droga, Nacionalna informacijska jedinica za opojne droge; 2007.
Search in Google Scholar Back to article
3. United Nations Office on Drugs and Crime. The challenge of new Psychoactive substances, Global SMART Programme, 2013 [displayed 14 May 2018]. Available at https://www.unodc.org/documents/scientific/NPS_Report.pdf
Search in Google Scholar Back to article
4. Centers for Disease Control and Prevention. Opioids drive continued increase in drug overdose deaths [displayed 20 February, 2013]. Available at http://www.cdc.gov/media/
Search in Google Scholar Back to article
5. Pinnamanemi K, Sievers RE, Sharma R, Selchau A M, Gutierrez G, Nordsieck EJ, Su R, An S, Chen Q, Wang X, Derakhshandeh R, Aschbacher K, Heiss C, Glantz SA, Schick SF, Springer ML. Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function. Nicotine Tob Res 2014;16:584-90. doi: 10.1093/ntr/ntt18910.1093/ntr/ntt189397748624302638
Open DOI Search in Google Scholar Back to article
6. ACMD. Consideration of the major cannabinoid agonists, 2009 [displayed 14 May 2018]. Available at http://www.namsdl.org/library/E2E91AB8-1372-636C-DDFC2BA64093B64C/
Search in Google Scholar Back to article
7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol. EU Drug Markets Report: In-Depth Analysis. Lisbon: EMCDDA, Europol; 2016.
Search in Google Scholar Back to article
8. Dargan PI, Wood DM, editors. Novel Psychoactive Substances: Classification, Pharmacology and Toxicology. London: Academic Press/Elsevier; 2013. doi: 10.1016/C2011-0-04205-910.1016/C2011-0-04205-9
Open DOI Search in Google Scholar Back to article
9. Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol 2015;5:97-132. doi: 10.1177/204512531455953910.1177/2045125314559539452144026240749
Open DOI Search in Google Scholar Back to article
10. Katselou M, Papoutsis I, Nikolaou PD, Spiliopoulou C, Athanaselis S. α-PVP (“flakka”): a new synthetic cathinone invades the drug arena. Forensic Toxicol 2016;34:41-50. doi: 10.1007/s11419-015-0298-110.1007/s11419-015-0298-1
Search in Google Scholar Back to article
11. Rojek S, Klys M, Maciow-Glab, Kula K, Strona M. Cathinones derivatives-related deaths as exemplified by two fatal cases involving matcathinone with 4-methylmatcathinone and 4-methylethcathinone. Drug Test Anal 2014;6:770-7. doi: 10.1002/dta.161510.1002/dta.161524550156
Open DOI Search in Google Scholar Back to article
12. Rösner P, Junge T, Westphal F, Fritschi G. Mass Spectra of Designer Drugs 2015. Weinheim: Wiley; 2015.
Search in Google Scholar Back to article
13. Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG). Mass Spectral Library [displayed 23 May 2018]. Available at http://www.swgdrug.org/ms.htm
Search in Google Scholar Back to article
14. Vaiano F, Busardò FP, Palumbo D, Kyriakou C, Fioravanti A, Catalani V, Mari F, Bertol E. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC–MS/MS and application to real cases. J Pharmaceut Biomed 2016;129: 441-9. doi: 10.1016/j.jpba.2016.07.00910.1016/j.jpba.2016.07.00927490334
Open DOI Search in Google Scholar Back to article
15. European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA). European information system and database on new drugs [displayed 23 May 2018]. Available at https://ednd-cma.emcdda.europa.eu/
Search in Google Scholar Back to article
16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report: Trends and Developments 2014. Lisbon: EMCDDA; 2014. doi: 10.2810/3230610.2810/32306
Open DOI Search in Google Scholar Back to article
17. Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O. Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 2015;33:45-53. doi: 10.1007/s11419-014-0245-610.1007/s11419-014-0245-6
Open DOI Search in Google Scholar Back to article
18. Hess C, Stockhausen S, Kernbach-Wighton G, Madea B. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids? Forensic Sci Int 2015;257:e6-11. doi: 10.1016/j.forsciint.2015.08.01210.1016/j.forsciint.2015.08.01226363623
Open DOI Search in Google Scholar Back to article
19. Andersson M, Diao X, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry. Rapid Commun Mass Sp 2016;30:1067-78. doi: 10.1002/rcm.753810.1002/rcm.753827003044
Open DOI Search in Google Scholar Back to article

A case of synthetic cannabinoid poisoning in Croatia

References

Paradigm

My account